[
  {
    "ts": null,
    "headline": "BMY Wins EC Nod for Label Expansion of CAR T Cell Therapy Breyanzi (Revised)",
    "summary": "Bristol Myers wins EC approval to expand Breyanzi's label, adding MCL patients to its growing roster of European CAR-T indications.",
    "url": "https://finnhub.io/api/news?id=dbc803aa3e2ae45839746c9cb5263416028cbbf30986a939231f4833a5310213",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764232860,
      "headline": "BMY Wins EC Nod for Label Expansion of CAR T Cell Therapy Breyanzi (Revised)",
      "id": 137620865,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol Myers wins EC approval to expand Breyanzi's label, adding MCL patients to its growing roster of European CAR-T indications.",
      "url": "https://finnhub.io/api/news?id=dbc803aa3e2ae45839746c9cb5263416028cbbf30986a939231f4833a5310213"
    }
  },
  {
    "ts": null,
    "headline": "Thanksgiving: Top 10 Most Innovative BioPharma Drugs In Phase 3",
    "summary": "Highlighting 10 innovative late-stage BioPharma drugs with the potential to reshape treatment paradigms and industry dynamics. Click here to read our picks.",
    "url": "https://finnhub.io/api/news?id=957425ce99f347f8ced0b3b60d44d11301701358932b1cbe7eb457febabbcede",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764228044,
      "headline": "Thanksgiving: Top 10 Most Innovative BioPharma Drugs In Phase 3",
      "id": 137620245,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/457734143/image_457734143.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Highlighting 10 innovative late-stage BioPharma drugs with the potential to reshape treatment paradigms and industry dynamics. Click here to read our picks.",
      "url": "https://finnhub.io/api/news?id=957425ce99f347f8ced0b3b60d44d11301701358932b1cbe7eb457febabbcede"
    }
  }
]